U.S. IPO Week Ahead: Just 2 Small IPOs During Election Week
U.S. IPO Week Ahead: Just 2 Small IPOs During Election Week.....»»
The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear
Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»
Jim Cramer"s week ahead: We need more downside before I"m ready to get more positive
Overbought markets "tend to get hit with sell-offs, especially when we're being flooded with shoddy IPOs," Jim Cramer says......»»
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Biotech stocks rebounded in last week after declining modestly in the previous week. read more.....»»
U.S. IPO Week Ahead: Summer"s Last Wave With 5 IPOs
U.S. IPO Week Ahead: Summer"s Last Wave With 5 IPOs.....»»
Wall Street edges higher ahead of major earnings, central bank meetings
U.S. stocks eked out small gains on Monday as investors were wary of making big bets ahead of key central bank meetings on interest rates and waited for earnings from marquee companies including Facebook and Amazon due later this week......»»
U.S. IPO Week Ahead: A Flurry Of IPOs Expected To Launch July Roadshows
U.S. IPO Week Ahead: A Flurry Of IPOs Expected To Launch July Roadshows.....»»
Stocks open slightly higher as investors eye Trump-Xi meeting later this week
Stocks opened with small gains Monday as investors looked ahead t.....»»
Canada set to approve hotly-debated pipeline expansion, Trudeau unlikely to benefit
Canada looks set to approve a hotly-debated plan to expand an oil pipeline this week, people familiar with the process told Reuters, but the move is unlikely to help Prime Minister Justin Trudeau rebuild flagging support ahead of an October election......»»
U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing
U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»
U.S. IPO Week Ahead: No IPOs But These 12 Deals Can Hop Back In After Easter
U.S. IPO Week Ahead: No IPOs But These 12 Deals Can Hop Back In After Easter.....»»
Cramer"s game plan: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnings and stock trading......»»
Cramer: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnuings and stock trading......»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs
U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs.....»»
US IPO Week Ahead: Pinterest and Zoom headline year"s busiest week with 8 IPOs
A whopping eight IPOs plan.....»»
India"s central bank cuts lending rate to 6%
India's central bank has lowered its key interest rate by a quarter of a percentage point to 6% to strengthen domestic growth ahead of a national election next week......»»